Movin (Cinnarizine, Dimenhydrinate)

Cinnarizine and Dimenhydrinate, the active ingredients in Movin, are an antihistamine and calcium‑channel blocker presented as an oral tablet for oral use. They are employed to alleviate motion‑induced vertigo, nausea and vomiting in adults, adolescents and children over six years of age.

GNH USA supplies Movin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled batches for global distribution and meeting regulatory requirements of the European Union market. The product is manufactured under GMP standards and shipped in tamper‑evident packaging.

Movin, containing cinnarizine and dimenhydrinate, is indicated for conditions affecting the vestibular system and gastrointestinal tract related to motion.

- Motion sickness: Reduces dizziness, nausea and vomiting associated with travel by land, sea or air. - Vertigo: Alleviates spinning sensations and balance disturbances caused by inner‑ear disorders. - Nausea and vomiting: Controls acute episodes of nausea and vomiting not related to motion, such as postoperative or medication‑induced cases.

Adverse reactions to Movin are generally mild but can vary in frequency and severity.

Common Side Effects: - Drowsiness - Dry mouth - Headache

Serious or Rare Side Effects: - Extrapyramidal symptoms (e.g., tremor, rigidity) - Severe allergic reaction (anaphylaxis) - Cardiac arrhythmia

When using Movin, consider the following safety measures. - Avoid operating machinery: Drowsiness may impair alertness. - Use with caution in the elderly: Increased sensitivity to sedative effects. - Do not combine with other antihistamines or sedatives without medical advice. - Monitor for signs of extrapyramidal reactions, especially with prolonged use. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Movin may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Concomitant use with central nervous system depressants (e.g., benzodiazepines, opioids). - Combination with other antihistamines. - Use with monoamine oxidase inhibitors (MAOIs).

Moderate Interactions (Monitor Closely): - Alcohol consumption. - Anticholinergic drugs (e.g., atropine, scopolamine). - CYP2D6 substrates that may have altered metabolism. - Loop diuretics (potential additive hypotensive effect). - Other antiemetics with overlapping mechanisms.